Cargando…

Bupropion Slow Release vs Placebo With Adaptive Incentives for Cocaine Use Disorder in Persons Receiving Methadone for Opioid Use Disorder: A Randomized Clinical Trial

IMPORTANCE: Opioid-stimulant co-use is a common problem with few evidence-based treatments. OBJECTIVE: To examine bupropion slow release (SR) enhancement of a tailored abstinence incentive program for stimulant use in persons with opioid use disorder. DESIGN, SETTING, AND PARTICIPANTS: This 26-week,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ware, Orrin D., Sweeney, Mary M., Cunningham, Colin, Umbricht, Annie, Stitzer, Maxine, Dunn, Kelly E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018324/ https://www.ncbi.nlm.nih.gov/pubmed/36920397 http://dx.doi.org/10.1001/jamanetworkopen.2023.2278

Ejemplares similares

Slow release oral morphine versus methadone for the treatment of opioid use disorder
por: Klimas, Jan, et al.
Publicado: (2019)

Buprenorphine treatment retention and comorbidities among patients with opioid use disorder in a primary care setting
por: Sweeney, Mary M., et al.
Publicado: (2022)

Factors related to substance use treatment attendance after peer recovery coach intervention in the emergency department
por: Ware, Orrin D., et al.
Publicado: (2022)

Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemic
por: Dunn, Kelly E., et al.
Publicado: (2021)

An implementation-focused process evaluation of an incentive intervention effectiveness trial in substance use disorders clinics at two Veterans Health Administration medical centers
por: Hagedorn, Hildi J, et al.
Publicado: (2014)

Practical Technology for Expanding and Improving Substance Use Disorder Treatment: Telehealth, Remote Monitoring, and Digital Health Interventions
por: Sweeney, Mary M., et al.
Publicado: (2022)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes
por: Taylor, Erin A., et al.
Publicado: (2023)

The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: a prospective cohort study
por: Rosic, Tea, et al.
Publicado: (2017)

Modafinil does not reduce cocaine use in methadone-maintained individuals
por: DeVito, Elise E., et al.
Publicado: (2022)

Implementation of methadone therapy for opioid use disorder in Russia – a modeled cost-effectiveness analysis
por: Idrisov, Bulat, et al.
Publicado: (2017)

Opioid Use Disorder Induces Oxidative Stress and Inflammation: The Attenuating Effect of Methadone Maintenance Treatment
por: Salarian, Ali, et al.
Publicado: (2018)

Laser meridian massage decreased craving in men with opioid use disorder on methadone maintenance treatment
por: Hu, Wen-Long, et al.
Publicado: (2022)

Bupropion Treatment for Stimulant Withdrawal in a Patient With Substance Use Disorder and Unspecified Bipolar Disorder
por: Khan, Daanish Y, et al.
Publicado: (2023)

Participation in a Hospital Incentive Program for Follow-up Treatment for Opioid Use Disorder
por: Kilaru, Austin S., et al.
Publicado: (2020)

The association between health conditions and cannabis use in patients with opioid use disorder receiving methadone maintenance treatment
por: Shams, Ieta, et al.
Publicado: (2019)

Association between methadone dose and concomitant cocaine use in methadone maintenance treatment: a register-based study
por: Baumeister, Marcus, et al.
Publicado: (2014)

Possible Addiction Transference From Cocaine Insufflation to Oral Bupropion in Bipolar Patient
por: Costa, Carolina, et al.
Publicado: (2015)

Metoprolol treatment of dual cocaine and bupropion cardiovascular and central nervous system toxicity
por: Richards, John R., et al.
Publicado: (2018)

Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial
por: Bastien, Gabriel, et al.
Publicado: (2022)

A Prospective Study to Investigate Predictors of Relapse among Patients with Opioid Use Disorder Treated with Methadone
por: Naji, Leen, et al.
Publicado: (2016)

Characterizing opioid use disorder patients who have received medication trials with both buprenorphine and methadone
por: Wilder, Christine M, et al.
Publicado: (2015)

Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada
por: Joudrey, Paul J., et al.
Publicado: (2021)

U.S. student pharmacist perceptions of the pharmacist’s role in methadone for opioid use disorder: A qualitative study
por: Hohmeier, Kenneth C, et al.
Publicado: (2021)

Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder
por: McCarthy, Brian, et al.
Publicado: (2023)

Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study
por: Bawor, Monica, et al.
Publicado: (2015)

The impact of cocaine and heroin on the placental transfer of methadone
por: Malek, Antoine, et al.
Publicado: (2009)

The treatment of cocaine use disorder
por: Kampman, Kyle M.
Publicado: (2019)

Decreased Level of Blood MicroRNA-133b in Men with Opioid Use Disorder on Methadone Maintenance Therapy
por: Hsu, Chih-Wei, et al.
Publicado: (2019)

Gender Differences on Methadone Maintenance Treatment Outcome among Patients with Opioid use Disorder: A Systematic Review
por: Mohemmad Rizal, Mohemmad Redzuan, et al.
Publicado: (2020)

Facilitators and Barriers to Nurse Practitioners Prescribing Methadone for Opioid Use Disorder in Nova Scotia: A Qualitative Study
por: Bates, Aaron E., et al.
Publicado: (2021)

Strategies for Transfer From Methadone to Buprenorphine for Treatment of Opioid Use Disorders and Associated Outcomes: A Systematic Review
por: Lintzeris, Nicholas, et al.
Publicado: (2022)

The effect of a methadone-initiated memory reconsolidation updating procedure in opioid use disorder: A translational study
por: Yue, Jing-Li, et al.
Publicado: (2022)

Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy
por: Krawczyk, Noa, et al.
Publicado: (2023)

Effectiveness of Conditioned Open-label Placebo With Methadone in Treatment of Opioid Use Disorder: A Randomized Clinical Trial
por: Belcher, Annabelle M., et al.
Publicado: (2023)

Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty “Second Chance” Methadone Program
por: Moses, Tabitha E, et al.
Publicado: (2022)

Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 4′-OH-bupropion in vitro
por: Sager, Jennifer E., et al.
Publicado: (2016)

ALDH2 Gene: Its Effects on the Neuropsychological Functions in Patients with Opioid Use Disorder Undergoing Methadone Maintenance Treatment
por: Lee, Po-Wei, et al.
Publicado: (2020)

Exploring the experiences of clients receiving opioid use disorder treatment at a methadone clinic in Kenya: a qualitative study
por: Kiburi, Sarah Kanana, et al.
Publicado: (2022)

Patient perspectives on community pharmacy administered and dispensing of methadone treatment for opioid use disorder: a qualitative study in the U.S.
por: Wu, Li-Tzy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ium4pnlr7ll1q045bn05ppu2jl